NAP expression analysis in bcr-abl negative MPN.

NAP expression analysis in bcr-abl negative MPN. - NAP expression analysis in bcr-abl negative MPN.

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000032878

Enrollment

Registered

2018-12-31

Start date

2018-06-05

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

MPN

Interventions

JAK2-V617F mutants CALR mutants Normal control

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: MPN patients who is known genetic mutation.

Exclusion criteria

Exclusion criteria: Non.

Design outcomes

Primary

Measure	Time frame
Difference in NAP expression level according to the genetic mutation in a MPN patient.	—

Countries

Japan

Contacts

Public ContactToshinori Kondo

Kawasaki Medical School Hematology

kondot@med.kawasaki-m.ac.jp0864621111

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026